Research and Innovation Translation Partnerships in Point-of-Care Technologies Conference and Technology Showcase - CIMIT MAIN

Responsive Image
The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Programs and Offerings

null Research and Innovation Translation Partnerships in Point-of-Care Technologies Conference and Technology Showcase

Research and Innovation Translation Partnerships in Point-of-Care Technologies Conference and Technology Showcase

This two-day conference will bring together researchers, technology developers, clinicians, and industry partners from all NIBIB Point of Care Technology Network (POCTRN) centers, regulatory administrators, non-government organization (NGO) leaders, and investors network to discuss complementary expertise and resources to accelerate point-of-care and home-based diagnostic technology innovation, validation, and commercialization.

When: Tuesday, November 28, 2023 - 8:30 AM to Wednesday, November 29, 2023 - 6:30 PM 

Registration for this event has ended.

 

News and Events

Learning How to Translate and Commercialize Neurotechnology

Read MoreAboutLearning How to Translate and Commercialize Neurotechnology »

RADx® Tech Independent Test Assessment Program (ITAP) for Hepatitis B Virus

Read MoreAboutRADx® Tech Independent Test Assessment Program (ITAP) for Hepatitis B Virus »

National Institutes of Health award $17 million for projects in the Blueprint MedTech Program

Read MoreAboutNational Institutes of Health award $17 million for projects in the Blueprint MedTech Program »

Funding Opportunity for Neurotech Innovations: Apply for funding up to $500K

Read MoreAboutFunding Opportunity for Neurotech Innovations: Apply for funding up to $500K »

Rapid Acceleration of Diagnostics Technology (RADx® Tech) Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays (ACT ENDO) Challenge

Read MoreAboutRapid Acceleration of Diagnostics Technology (RADx® Tech) Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays (ACT ENDO) Challenge »

FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test

Test Enables Single-Visit Testing and Treatment for Hepatitis C Read MoreAboutFDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test »

NIH collaborates with diagnostics manufacturers on obtaining authorization of multiplex tests

Read MoreAboutNIH collaborates with diagnostics manufacturers on obtaining authorization of multiplex tests »

NIH awards interim prizes in fetal diagnostic and monitoring technology competition

Read MoreAboutNIH awards interim prizes in fetal diagnostic and monitoring technology competition »

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, Cimit has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.